tiprankstipranks
Hydreight Technologies Inc (TSE:NURS)
:NURS
NURS
Hydreight Technologies Inc
RESEARCH TOOLSreports

Hydreight Technologies Inc (NURS) Price & Analysis

36 Followers

NURS Stock Chart & Stats

C$4.30
C$0.02(0.48%)
At close: 4:00 PM EDT
C$4.30
C$0.02(0.48%)
Day’s Range― - ―
52-Week RangeC$2.38 - C$5.59
Previous CloseN/A
Volume56.82K
Average Volume (3M)110.80K
Market Cap
C$195.06M
Enterprise ValueC$232.44
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)26.9
Beta1.00
Next Earnings
Dec 02, 2026
EPS Estimate
0.07
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding53,660,930
10 Day Avg. Volume165,687
30 Day Avg. Volume110,796
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
C$7.88
Price Target Upside83.14% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.28
Revenue Forecast (FY)C$145.38M

Hydreight Technologies Inc News

Hydreight Technologies price target lowered to C$6.75 from C$8.25 at Canaccord
Hydreight Technologies price target lowered to C$6.75 from C$8.25 at Canaccord
Canaccord lowered the firm’s price target on Hydreight Technologies (HYDTF) to C$6.75 from C$8.25 and keeps a Speculative...
6d ago
Hydreight Posts Record Q2 2026 Revenue on Surging Digital Health and Pharmacy Sales
Hydreight Posts Record Q2 2026 Revenue on Surging Digital Health and Pharmacy Sales
Hydreight Technologies Inc ( ($TSE:NURS) ) has issued an announcement. Hydreight reported record second-quarter 2026 revenue of $28.0...
8d ago
Hydreight Posts Record Q2 Revenue as Digital Health Platform Scales Rapidly
Hydreight Posts Record Q2 Revenue as Digital Health Platform Scales Rapidly
Hydreight Technologies Inc ( ($TSE:NURS) ) just unveiled an announcement. Hydreight Technologies Inc. reported record second-quarter 2026 revenue...
8d ago
Hydreight Sets Q2 2026 Results Date and Investor Webcast to Highlight Platform Expansion
Hydreight Sets Q2 2026 Results Date and Investor Webcast to Highlight Platform Expansion
The latest announcement is out from Hydreight Technologies Inc ( ($TSE:NURS) ). Hydreight Technologies Inc., a rapidly growing...
12d ago
Hydreight Showcases Rapid Growth and Nationwide Healthcare Platform at Canaccord Conference
Hydreight Showcases Rapid Growth and Nationwide Healthcare Platform at Canaccord Conference
Hydreight Technologies Inc ( ($TSE:NURS) ) has shared an announcement. Hydreight Technologies, which operates a nationwide physician-supervised healthcare...
1M ago
Hydreight Earns Buy Rating on Explosive Growth, Scalable Platform, and Attractive Valuation vs. 12-Month EBITDA-Based Target
Hydreight Earns Buy Rating on Explosive Growth, Scalable Platform, and Attractive Valuation vs. 12-Month EBITDA-Based Target
Analyst Allen Klee of Maxim Group reiterated a Buy rating on Hydreight Technologies Inc, with a price target...
3M ago
Hydreight Takes Stake in Insu Therapeutics to Back Needle-Free Peptide Delivery
Hydreight Takes Stake in Insu Therapeutics to Back Needle-Free Peptide Delivery
An announcement from Hydreight Technologies Inc ( ($TSE:NURS) ) is now available. Hydreight Technologies Inc. has made a...
6M ago
Hydreight Technologies: Strong 2026 Growth Guidance, Operating Leverage, and Discounted Valuation Support Buy Rating
Hydreight Technologies: Strong 2026 Growth Guidance, Operating Leverage, and Discounted Valuation Support Buy Rating
Analyst Allen Klee from Maxim Group reiterated a Buy rating on Hydreight Technologies Inc and increased the price...
7M ago
Hydreight Sets $150 Million Baseline Revenue Target for 2026, Signals Margin Expansion
Hydreight Sets $150 Million Baseline Revenue Target for 2026, Signals Margin Expansion
Hydreight Technologies Inc ( ($TSE:NURS) ) just unveiled an update. Hydreight Technologies has issued baseline fiscal 2026 revenue...
7M ago
Hydreight Technologies sees FY26 revenue $150M
Hydreight Technologies sees FY26 revenue $150M
The company said, “Based on current internal planning assumptions, the Company expects fiscal 2026 revenue of approximately $150M,...
7M ago
Hydreight Technologies sees Q1 revenue $25M-$28M
Hydreight Technologies sees Q1 revenue $25M-$28M
The company said, “The Company expects revenue to increase throughout fiscal 2026 as several major partnerships, clients, and...
7M ago
Hydreight Raises $15 Million in Oversubscribed Bought-Deal to Accelerate U.S. Digital Health Expansion
Hydreight Raises $15 Million in Oversubscribed Bought-Deal to Accelerate U.S. Digital Health Expansion
Hydreight Technologies Inc ( ($TSE:NURS) ) has shared an announcement. Hydreight Technologies Inc. has closed an oversubscribed bought-deal...
7M ago
Hydreight Raises C$10 Million in Bought Deal to Accelerate U.S. Digital Healthcare Growth
Hydreight Raises C$10 Million in Bought Deal to Accelerate U.S. Digital Healthcare Growth
Hydreight Technologies Inc ( ($TSE:NURS) ) has shared an announcement. Hydreight Technologies Inc. has launched a C$10 million...
8M ago
Hydreight enters distribution agreement with Health Screen Collective
Hydreight enters distribution agreement with Health Screen Collective
Hydreight Technologies (HYDTF) announced its entry into the rapidly expanding at-home sexually transmitted infection pre-screening market through an...
8M ago

NURS FAQ

What was Hydreight Technologies Inc’s price range in the past 12 months?
Hydreight Technologies Inc lowest stock price was C$2.38 and its highest was C$5.59 in the past 12 months.
    What is Hydreight Technologies Inc’s market cap?
    Hydreight Technologies Inc’s market cap is C$195.06M.
      When is Hydreight Technologies Inc’s upcoming earnings report date?
      Hydreight Technologies Inc’s upcoming earnings report date is Dec 02, 2026 which is in 85 days.
        How were Hydreight Technologies Inc’s earnings last quarter?
        Hydreight Technologies Inc released its earnings results on Sep 01, 2026. The company reported C$0.05 earnings per share for the quarter.
          Is Hydreight Technologies Inc overvalued?
          According to Wall Street analysts Hydreight Technologies Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Hydreight Technologies Inc pay dividends?
            Hydreight Technologies Inc does not currently pay dividends.
            What is Hydreight Technologies Inc’s EPS estimate?
            Hydreight Technologies Inc’s EPS estimate is 0.07.
              How many shares outstanding does Hydreight Technologies Inc have?
              Hydreight Technologies Inc has 53,660,930 shares outstanding.
                What happened to Hydreight Technologies Inc’s price movement after its last earnings report?
                Hydreight Technologies Inc reported an EPS of C$0.05 in its last earnings report. Following the earnings report the stock price went down -16.667%.
                  Which hedge fund is a major shareholder of Hydreight Technologies Inc?
                  Currently, no hedge funds are holding shares in TSE:NURS
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Hydreight Technologies Inc Stock Smart Score

                    9
                    Outperform
                    1
                    2
                    3
                    4
                    5
                    6
                    7
                    8
                    9
                    10

                    Analyst Consensus

                    Moderate Buy
                    Average Price Target:
                    C$7.88 (83.14% Upside)

                    Blogger Sentiment

                    Bullish
                    TSE:NURS Sentiment 100%
                    Sector Average ―

                    News Sentiment

                    Very Bullish
                    Bullish news 100%
                    Bearish news 0%

                    Technicals

                    SMA
                    Positive
                    20 days / 200 days
                    Momentum
                    -9.12%
                    12-Months-Change

                    Fundamentals

                    Return on Equity
                    ―
                    Trailing 12-Months
                    Asset Growth
                    675.61%
                    Trailing 12-Months
                    Learn more about TipRanks Smart Score
                    Top Smart Score Stocks >

                    Company Description

                    Hydreight Technologies Inc

                    Hydreight Technologies Inc provides health & wellness services. It offers a completely compliant turnkey business model for health professionals to offer fully licensed medical & health services. Its services include IV drip, Botox, COVID-19 testing, and other medical and medispa treatments at a location of the customer's choice.

                    Hydreight Technologies Inc (NURS) Earnings & Revenues

                    Historic Earnings Reports

                    NURS Stock 12 Month Forecast

                    Average Price Target

                    C$7.88
                    ▲(83.14% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"C$1","10":"C$10","3.25":"C$3.25","5.5":"C$5.5","7.75":"C$7.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$9.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":7.875,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$7.88</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":6.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$6.75</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,3.25,5.5,7.75,10],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2025","6":"Feb<br/>2026","9":"May<br/>2026","12":"Aug<br/>2026","25":"Aug<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.45,3.876923076923077,4.303846153846154,4.730769230769231,5.157692307692308,5.584615384615384,6.0115384615384615,6.438461538461539,6.865384615384615,7.292307692307692,7.719230769230769,8.146153846153847,8.573076923076922,{"y":9,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.45,3.7903846153846157,4.130769230769231,4.471153846153847,4.811538461538461,5.151923076923078,5.492307692307692,5.832692307692308,6.173076923076923,6.513461538461539,6.853846153846154,7.194230769230769,7.5346153846153845,{"y":7.875,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.45,3.703846153846154,3.957692307692308,4.211538461538462,4.4653846153846155,4.719230769230769,4.973076923076923,5.226923076923077,5.480769230769231,5.734615384615385,5.9884615384615385,6.242307692307692,6.496153846153846,{"y":6.75,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":3.3,"date":1756674000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.7,"date":1759266000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.82,"date":1761948000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.43,"date":1764540000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.73,"date":1767218400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.98,"date":1769896800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.77,"date":1772316000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.57,"date":1774990800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.9,"date":1777582800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.73,"date":1780261200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":4.77,"date":1782853200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.99,"date":1785531600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.45,"date":1788210000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Detailed Analyst Forecast >

                    Technical Analysis

                    Overall Consensus
                    Strong Sell
                    3Bullish
                    5Neutral
                    14Bearish
                    Bullish
                    Neutral
                    Bearish
                    Overall Consensus
                    3
                    5
                    14
                    Technical Analysis
                    3
                    5
                    2
                    Moving Averages
                    0
                    0
                    12
                    Technical Analysis >
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    EKG
                    Cardiocomm Solutions
                    ―
                    ―
                    RHT.H
                    Reliq Health Technologies
                    ―
                    ―
                    AIDX
                    HEALWELL AI
                    ―
                    ―
                    KOVO
                    Kovo HealthTech Corporation
                    ―
                    ―
                    CSPN
                    CareSpan Health
                    ―
                    ―
                    Compare TSE:NURS Stocks >
                    Popular Stocks